The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Infection and Immunity
Catherine HyamsJeremy S Brown

Abstract

The Streptococcus pneumoniae capsule is vital for virulence and may inhibit complement activity and phagocytosis. However, there are only limited data on the mechanisms by which the capsule affects complement and the consequences for S. pneumoniae interactions with phagocytes. Using unencapsulated serotype 2 and 4 S. pneumoniae mutants, we have confirmed that the capsule has several effects on complement activity. The capsule impaired bacterial opsonization with C3b/iC3b by both the alternative and classical complement pathways and also inhibited conversion of C3b bound to the bacterial surface to iC3b. There was increased binding of the classical pathway mediators immunoglobulin G (IgG) and C-reactive protein (CRP) to unencapsulated S. pneumoniae, indicating that the capsule could inhibit classical pathway complement activity by masking antibody recognition of subcapsular antigens, as well as by inhibiting CRP binding. Cleavage of serum IgG by the enzyme IdeS reduced C3b/iC3b deposition on all of the strains, but there were still marked increases in C3b/iC3b deposition on unencapsulated TIGR4 and D39 strains compared to encapsulated strains, suggesting that the capsule inhibits both IgG-mediated and IgG-independent complement ...Continue Reading

References

Aug 1, 1978·The Journal of Clinical Investigation·G N GrossA K Pierce
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M R WesselsD L Kasper
Mar 1, 1981·Reviews of Infectious Diseases·J A Winkelstein
Apr 5, 2001·The New England Journal of Medicine·M J Walport
Sep 5, 2001·Molecular Immunology·J E Volanakis
Apr 3, 2002·The EMBO Journal·Ulrich von Pawel-RammingenLars Björck
Dec 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jeremy S BrownMarina Botto
Dec 9, 2003·Applied and Environmental Microbiology·Krzysztof TrzcinskiMarc Lipsitch
Jul 21, 2004·The Journal of Experimental Medicine·Mohamed ArredouaniLester Kobzik
Dec 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Katja WenigPeter Sondermann
Dec 4, 2004·Journal of Bacteriology·Angeliki MavroidiBrian G Spratt
Mar 30, 2005·Lancet·Jennifer BryceUNKNOWN WHO Child Health Epidemiology Reference Group
Jul 22, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jose YusteJeremy S Brown
Jul 26, 2005·Infection and Immunity·Sven HammerschmidtManfred Rohde
Mar 15, 2006·PLoS Genetics·Stephen D BentleyBrian G Spratt
Apr 7, 2006·The Journal of Biological Chemistry·Ling LuJing-Ren Zhang
May 6, 2006·American Journal of Respiratory Cell and Molecular Biology·Mohamed S ArredouaniLester Kobzik
May 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Judy K MoronaJames C Paton
Jul 29, 2006·BMC Microbiology·I SerranoM Ramirez
Sep 9, 2006·Clinical and Vaccine Immunology : CVI·Robert L Burton, Moon H Nahm
Nov 8, 2006·Infection and Immunity·Aaron L NelsonJeffrey N Weiser
Sep 12, 2007·PLoS Pathogens·Jose YusteJeremy S Brown
Jul 1, 1949·The Journal of Experimental Medicine·W B WOOD, M R SMITH
Oct 31, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael R JacobsAnne R Windau

❮ Previous
Next ❯

Citations

Jan 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Juan J CalixMoon H Nahm
Jul 22, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Gavin K Paterson, Carlos J Orihuela
Jul 8, 2011·Clinical Microbiology Reviews·Barry B Mook-KanamoriDiederik van de Beek
May 8, 2013·Infection and Immunity·Mirian DomenechJose Yuste
May 4, 2012·Journal of Clinical Microbiology·Marcus H LeungStephen H Gillespie
Feb 24, 2012·Canadian Journal of Microbiology·Marie KempfMarie-Laure Joly-Guillou
Sep 26, 2013·BMC Infectious Diseases·Susanna RicciGianni Pozzi
May 21, 2013·European Journal of Medical Research·Da-kang HuXiang-yang Li
Oct 25, 2011·PloS One·Catherine HyamsJeremy S Brown
Mar 14, 2012·PLoS Pathogens·Lucy J HathawayKathrin Mühlemann
Dec 4, 2013·Antioxidants & Redox Signaling·Alistair J Standish, Renato Morona
Jul 9, 2014·Annual Review of Microbiology·Cheryl Y M Okumura, Victor Nizet
Jun 4, 2015·Emerging Microbes & Infections·Daan de GouwFrits R Mooi
Oct 10, 2014·BioMed Research International·Abhinav UpadhyayKumar Venkitanarayanan
Nov 3, 2015·Expert Review of Proteomics·Mustapha Bittaye, Phil Cash
Sep 26, 2015·Human Vaccines & Immunotherapeutics·Ho NamkoongNaoki Hasegawa
Jan 4, 2012·Cellular Microbiology·Uwe KoppeBastian Opitz
Nov 17, 2012·Journal of Molecular Biology·Benjamin PluvinageAlisdair B Boraston
Mar 15, 2012·Microbes and Infection·Vishakha SabharwalMelinda M Pettigrew
May 14, 2011·Structure·Alicia Lammerts van BuerenAlisdair B Boraston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.